HAILONG VU: Open Payments
NPI 1578862256 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 4 payments from 4 companies in 2025. Trend: 2023 $383 · 2024 $325 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $165 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $119 |
| Alkermes, Inc. | 1 | $112 |
Products named: INGREZZA, Auvelity, CAPLYTA, LYBALVI.
Industry payments across CA — which companies pay providers there.
